⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28614501 | 0.97 | — | — | |
| SCHEMBL9741536 | 0.97 | — | — | |
| SCHEMBL28217455 | 0.97 | — | — | |
| SCHEMBL6013871 | 0.76 | — | — | |
| SCHEMBL562702 | 0.74 | KDM1A (0.63) | — | |
| SCHEMBL562701 | 0.74 | KDM1A (0.63) | — | |
| Diethylamine SCHEMBL27776705 | 0.74 | — | — | |
| SCHEMBL1018616 | 0.73 | — | — | |
| Diethylamine SCHEMBL29452965 | 0.72 | — | — | |
| SCHEMBL2009490 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119896673-A | Application of GLP-1R agonist and metformin in preparation of drugs for treating diabetes and complications thereof | 深圳信立泰药业股份有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-115305073-B | Gemini surfactant for preparing water-resistant water from stratum brine and preparation method thereof | 江苏海洋大学 | 2024-07-09 | — | — | CN | claimed |
| CN-115515938-B | Salts of FXIa inhibitor compounds, preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2024-05-10 | — | — | CN | claimed |
| EP-4351341-A1 | TICK CONTROL METHODS | Intervet International B.V. (NL) | 2024-04-17 | — | — | EP | claimed |
| CN-117693504-A | Salt of GLP-1R agonist compound, preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2024-03-12 | — | — | CN | claimed |
| CN-111819176-B | 4-azaindole compounds | 百时美施贵宝公司 | 2023-12-15 | — | — | CN | claimed |
| WO-2022258797-A1 | TICK CONTROL METHODS | INTERVET INTERNATIONAL B.V. (NL) | 2022-12-15 | — | — | WO | claimed |
| CN-110818712-A | 1-methyl-1, 3, 8-triazaspiro [4.5] decane-2, 4-dione, and synthesis method and intermediate product thereof | 南京红杉生物科技有限公司 | 2020-02-21 | — | — | CN | claimed |
| EP-2643000-A2 | THERAPEUTIC PIPERAZINES | Dart Neuroscience (Cayman) Ltd (KY) | 2013-10-02 | — | — | EP | claimed |
| WO-2012040258-A2 | THERAPEUTIC PIPERAZINES | HELICON THERAPEUTICS, INC. (US) | 2012-03-29 | — | — | WO | claimed |
| WO-2001038397-A1 | N-ALKYLATED PEPTIDES HAVING ANTIANGIOGENIC ACTIVITY | ABBOTT LABORATORIES (US) | 2001-05-31 | — | — | WO | claimed |
| WO-2001038347-A2 | PEPTIDES HAVING ANTIANGIOGENIC ACTIVITY | ABBOTT LABORATORIES (US) | 2001-05-31 | — | — | WO | claimed |
| WO-2001025234-A1 | QUINAZOLINONES AND ANALOGUES AND THEIR USE AS LOCAL ANESTHETICS | ADVANCED MEDICINE, INC. (US) | 2001-04-12 | — | — | WO | claimed |
| EP-1078002-A1 | PEPTIDE ANTIANGIOGENIC DRUGS | ABBOTT LABORATORIES (US) | 2001-02-28 | — | — | EP | claimed |
| WO-2000031063-A1 | SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS | G.D. SEARLE & CO. (US) | 2000-06-02 | — | — | WO | claimed |
| WO-1999061476-A1 | PEPTIDE ANTIANGIOGENIC DRUGS | ABBOTT LABORATORIES (US) | 1999-12-02 | — | — | WO | claimed |
| US-5807984-A | CONTROLLING DISEASES; PENTAPEPTIDES | BASF AKTIENEGESELLSCHAFT (DE) | 1998-09-15 | — | — | US | claimed |
| EP-0859786-A1 | PEPTIDE DERIVATIVES OF DOLASTATIN 15 AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 1998-08-26 | — | — | EP | claimed |
| WO-1997017364-A1 | PEPTIDE DERIVATIVES OF DOLASTATIN 15 AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 1997-05-15 | — | — | WO | claimed |
| US-4067916-A | TELOMERIZATION WITH A PERFLUOROETHYLENE OR PERFLUOROPROPYLENE | CIBA-GEIGY AG (CH) | 1978-01-10 | — | — | US | claimed |